Explore the latest scientific research on peptides, from healing compounds to cognitive enhancers. Evidence-based articles written for researchers and enthusiasts.
Comprehensive reviews of the latest peptide research findings
Amgen's MariTide is an antibody-peptide conjugate that activates GLP-1 while blocking GIP — the exact opposite of tirzepatide — and only needs to be injected once a month. Phase 2 data showed up to 20% weight loss, and Phase 3 MARITIME trials are now enrolling thousands. Here's why this drug could reshape the obesity treatment calendar.
Novo Nordisk's amycretin crams GLP-1 and amylin activity into one molecule — delivering up to 22% weight loss in early trials, available as both a shot and a pill, and heading into Phase 3 in 2026. Here's the science, the data, and what it means for the future of obesity treatment.
Discover peptide research organized by function and application
Peptides studied for tissue repair, wound healing, and regenerative properties. This category covers research on compounds that may support the body's natural healing processes.
GH-releasing peptides and secretagogues research. Explore studies on peptides that interact with growth hormone pathways and their potential applications.
Nootropic and brain-supportive peptides. Research on compounds studied for their potential effects on memory, focus, and neuroprotection.
Peptides studied for metabolic function, weight management, and energy regulation. Includes research on compounds affecting metabolism and body composition.
Comprehensive information on research peptides with molecular data
Mounjaro, Zepbound, LY3298176
The first FDA-approved dual GIP/GLP-1 receptor agonist, producing record-breaking weight loss results. Approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound).
Ozempic, Wegovy, Rybelsus
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. One of the most effective medications for weight loss, available as once-weekly injection or daily oral tablet.
Body Protection Compound-157 (Pentadecapeptide)
A synthetic 15-amino acid peptide derived from human gastric juice protein, extensively studied for tissue healing, gastrointestinal protection, and regenerative properties. One of the most researched peptides in regenerative medicine.
Thymosin Beta-4
A synthetic peptide derived from the active region of Thymosin Beta-4, widely researched for tissue repair, wound healing, and recovery. TB-500 is one of the most popular healing peptides in research communities.
Bremelanotide, Vyleesi
An FDA-approved melanocortin receptor agonist that works in the brain to enhance sexual desire and arousal. Marketed as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Ipamorelin Acetate
A highly selective growth hormone releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol and prolactin. Known for its clean side effect profile and synergy with GHRH analogs.
Stay up to date with the newest research
Amgen's MariTide is an antibody-peptide conjugate that activates GLP-1 while blocking GIP — the exact opposite of tirzepatide — and only needs to be injected once a month. Phase 2 data showed up to 20% weight loss, and Phase 3 MARITIME trials are now enrolling thousands. Here's why this drug could reshape the obesity treatment calendar.
Novo Nordisk's amycretin crams GLP-1 and amylin activity into one molecule — delivering up to 22% weight loss in early trials, available as both a shot and a pill, and heading into Phase 3 in 2026. Here's the science, the data, and what it means for the future of obesity treatment.
On March 18, 2026, the FDA approved something that dermatologists have wanted for decades: a once-daily pill that clears psoriasis as effectively as injectable biologics. ICOTYDE is a cyclic peptide that blocks the IL-23 receptor — and it's just the beginning of what oral peptides could do for autoimmune disease.
Your body is accumulating cells that refuse to die and refuse to do their jobs — secreting inflammatory signals that accelerate aging across every organ. FOXO4-DRI is the precision peptide engineered to eliminate them. Here's what eight years of research actually shows.
Our team continuously reviews and synthesizes the latest scientific literature to bring you accurate, up-to-date information on peptide research.